Stock under Rs. 100 primarily engaged in the manufacturing of x-ray films and trading into specialty x-ray films and medical equipment hit a 20 percent upper circuit in the day’s trade upon signing distribution agreement for the sale of products used in the Non-Destructive Testing.
Price Action
With a market capitalization of Rs. 33 Crores, the shares of Choksi Imaging Limited hit a 20 percent upper circuit in the day’s trade at Rs. 85.17 per equity share, from its previous day’s close price of Rs. 70.98.
What Happened
Choksi Imaging Limited has signed a distribution agreement with Kronix NDT Corporation(Supplier) for the sale of products used in the Non-Destructive Testing industry and related accessories as per the terms and conditions of the said agreement for one year.
The above agreement is in the best interest of the Company, as it will enable the Company to further diversify and strengthen its product portfolio, increase its market presence and have a significant positive impact on its revenue.
About the Company
Choksi Imaging Limited is primarily engaged in dealing in the manufacturing of x-ray films and trading into specialty x-ray films and medical equipment. The Company’s product offerings include Ultrasound & Color Dropller, X-ray Film & chemicals, X-ray Accessories, and NDT.
Financials and Ratios
Its revenue from operations grew by 1000 percent from Rs. 0.52 Crores in Q2FY24 to Rs. 5.72 Crores in Q1FY25, accompanied by a loss of Rs. 47 Lakhs to a profit of Rs. 24 Lakhs
In terms of return ratios, it has reported a return on equity (ROE) of 4.03 percent and a return on capital employed (ROCE) of 2.6 percent. In terms of liquidity, it has reported a debt-to-equity ratio of 0.14.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
